Showing results (21-30 of 3,466) with videos related to
Sort By:
Pageof 347
Clinical Pharmacokinetics|April 22, 2016
Pharmacogenetics of UGT1A4, UGT2B7 and UGT2B15 and Their Influence on Tamoxifen Disposition in Asian Breast Cancer PatientsNatalia Sutiman, Joanne Siok Liu Lim, Thomas E Muerdter, et al.Clinical Pharmacokinetics|April 24, 2016
Pharmacokinetic Drug Interactions with Tobacco, Cannabinoids and Smoking Cessation ProductsGail D Anderson, Lingtak-Neander ChanClinical Pharmacokinetics|May 4, 2016
Population Pharmacokinetic Modelling and Bayesian Estimation of Tacrolimus Exposure: Is this Clinically Useful for Dosage Prediction Yet?Emily Brooks, Susan E Tett, Nicole M Isbel, et al.Clinical Pharmacokinetics|May 5, 2016
Does Weight Impact Anidulafungin Pharmacokinetics?Vincent J Lempers, Anne van Rongen, Eric P van Dongen, et al.Clinical Pharmacokinetics|March 9, 2016
Population Pharmacokinetics of Edoxaban in Patients with Non-Valvular Atrial Fibrillation in the ENGAGE AF-TIMI 48 Study, a Phase III Clinical TrialElke H J Krekels, Ronald Niebecker, Mats O Karlsson, et al.Clinical Pharmacokinetics|March 1, 1989
Food interactions with sustained-release theophylline preparations. A reviewJ H JonkmanClinical Pharmacokinetics|April 1, 1989
Clinical pharmacokinetic properties of the macrolide antibiotics. Effects of age and various pathophysiological states (Part I)P Periti, T Mazzei, E Mini, et al.Clinical Pharmacokinetics|April 1, 1989
Clinical pharmacokinetic considerations in the control of oral anticoagulant therapyH G Shetty, A G Fennerty, P A RoutledgeClinical Pharmacokinetics|February 20, 2016
Drug-Drug Interactions Between the Anti-Hepatitis C Virus 3D Regimen of Ombitasvir, Paritaprevir/Ritonavir, and Dasabuvir and Eight Commonly Used Medications in Healthy VolunteersAkshanth R Polepally, Jennifer R King, Bifeng Ding, et al.Clinical Pharmacokinetics|July 3, 2013
Differences in cytochrome p450-mediated pharmacokinetics between chinese and caucasian populations predicted by mechanistic physiologically based pharmacokinetic modellingZoe E Barter, Geoffrey T Tucker, Karen Rowland-YeoPageof 347